Physician profile
Armando O Martinez
NPI 1043305949
$26,303.04
in general payments reported to CMS, 2019-2025
61 companies · $1,938 in 2025
The $1,938 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,413 · 2020: $1,895 · 2021: $4,871 · 2022: $4,600 · 2023: $4,344 · 2024: $4,241 · 2025: $1,938.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,523.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $3,578.92 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $3,392.26 | 2019-2025 | Airsupra, Breztri, Farxiga |
| E.R. Squibb & Sons, L.L.C. | $1,313.88 | 2019-2025 | Opdivo, Abecma, Augtyro |
| Glaxosmithkline, LLC. | $998.59 | 2020-2023 | Arexvy, Shingrix |
| Amgen INC. | $955.40 | 2019-2024 | Evenity, Lumakras, Nplate |
| Novo Nordisk INC | $918.08 | 2019-2022 | |
| Janssen Biotech, INC. | $906.54 | 2021-2025 | Carvykti, Rybrevant, Akeega |
| Regeneron Healthcare Solutions, INC. | $846.28 | 2021-2025 | Libtayo |
| Incyte Corporation | $805.22 | 2021-2024 | Jakafi, Pemazyre, Monjuvi |
| Genentech USA, INC. | $755.51 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $706.61 | 2019-2025 | |
| Abbvie INC. | $664.79 | 2019-2022 | |
| Lilly USA, LLC | $631.70 | 2019-2024 | Jaypirca |
| Genzyme Corporation | $629.63 | 2020-2025 | |
| Eisai INC. | $490.98 | 2021-2023 |
Show all 61 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Armando Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.